Therapeutic Solutions Valuation
| TSOI Stock | USD 0.0005 0.0001 16.67% |
Therapeutic Solutions seems to be fairly valued based on Macroaxis valuation methodology. Our model measures the value of Therapeutic Solutions from inspecting the company fundamentals such as Current Valuation of 21.6 M, shares owned by insiders of 27.98 %, and Return On Equity of -12.27 as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Therapeutic Solutions' price fluctuation is out of control at this time. Calculation of the real value of Therapeutic Solutions is based on 3 months time horizon. Increasing Therapeutic Solutions' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Therapeutic Solutions is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Therapeutic Pink Sheet. However, Therapeutic Solutions' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.0E-4 | Real 4.8E-4 | Hype 6.25E-4 | Naive 3.02E-4 |
The intrinsic value of Therapeutic Solutions' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Therapeutic Solutions' stock price.
Estimating the potential upside or downside of Therapeutic Solutions International helps investors to forecast how Therapeutic pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Therapeutic Solutions more accurately as focusing exclusively on Therapeutic Solutions' fundamentals will not take into account other important factors: Therapeutic Solutions Total Value Analysis
Therapeutic Solutions International is at this time estimated to have valuation of 21.6 M with market capitalization of 7.82 M, debt of 15.53 K, and cash on hands of 197.29 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Therapeutic Solutions fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
21.6 M | 7.82 M | 15.53 K | 197.29 K |
Therapeutic Solutions Investor Information
About 28.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.0. Therapeutic Solutions had not issued any dividends in recent years. Based on the key indicators related to Therapeutic Solutions' liquidity, profitability, solvency, and operating efficiencyBased on the analysis of, Therapeutic Solutions International is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Therapeutic Solutions Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Therapeutic Solutions has an asset utilization ratio of 8.51 percent. This signifies that the Company is making $0.0851 for each dollar of assets. An increasing asset utilization means that Therapeutic Solutions International is more efficient with each dollar of assets it utilizes for everyday operations.Therapeutic Solutions Ownership Allocation
Therapeutic Solutions shows a total of 2.61 Billion outstanding shares. Therapeutic Solutions maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Therapeutic Solutions Profitability Analysis
The company reported the previous year's revenue of 145.96 K. Net Loss for the year was (2.96 M) with profit before overhead, payroll, taxes, and interest of 103.41 K.About Therapeutic Solutions Valuation
An absolute valuation paradigm, as applied to Therapeutic Pink Sheet, attempts to find the value of Therapeutic Solutions based on its fundamental and basic technical indicators. By analyzing Therapeutic Solutions's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Therapeutic Solutions's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Therapeutic Solutions. We calculate exposure to Therapeutic Solutions's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Therapeutic Solutions's related companies.Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases. Therapeutic Solutions International, Inc. was founded in 2007 and is based in Elk City, Idaho. Therapeutic Solutions operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.
8 Steps to conduct Therapeutic Solutions' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Therapeutic Solutions' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Therapeutic Solutions' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Therapeutic Solutions' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Therapeutic Solutions' revenue streams: Identify Therapeutic Solutions' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Therapeutic Solutions' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Therapeutic Solutions' growth potential: Evaluate Therapeutic Solutions' management, business model, and growth potential.
- Determine Therapeutic Solutions' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Therapeutic Solutions' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Therapeutic Solutions Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 2.3 B | |
| Retained Earnings | -14 M |
Complementary Tools for Therapeutic Pink Sheet analysis
When running Therapeutic Solutions' price analysis, check to measure Therapeutic Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Therapeutic Solutions is operating at the current time. Most of Therapeutic Solutions' value examination focuses on studying past and present price action to predict the probability of Therapeutic Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Therapeutic Solutions' price. Additionally, you may evaluate how the addition of Therapeutic Solutions to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |